Black Diamond Therapeutics, Inc. (BDTX) vs OnKure Therapeutics, Inc. (OKUR)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and OnKure Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
OKUR
OnKure Therapeutics, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 12:29 PM EDT
Total return — BDTX vs OKUR
growth of $100 · dividends reinvested · last 5yBDTX -92.0% (-39.7%/yr)OKUR -98.2% (-55.5%/yr)BDTX compounded faster over this window
BDTX OKUR
BDTX vs OKUR: by the numbers
- •BDTX is the larger company ($109M vs $102M market cap).
- •BDTX is profitable (31.95% net margin) while OKUR runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BDTX | OKUR |
|---|---|---|
| P/B ratio | 1.13 | 0.60 |
Profitability
| Metric | BDTX | OKUR |
|---|---|---|
| Gross margin | 99.54% | 0.00% |
| Operating margin | 28.39% | 0.00% |
| Net margin | 31.95% | 0.00% |
| ROE | -44.29% | -34.11% |
| ROIC | -47.54% | -35.98% |
Growth (annualized)
| Metric | BDTX | OKUR |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | -47.19% |
Frequently asked
- Is BDTX or OKUR more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus OKUR at 0.00%.
- How have BDTX and OKUR total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and OKUR delivered -47.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.